GOLDMAN SACHS GROUP INC - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 92 filers reported holding CORMEDIX INC in Q3 2023. The put-call ratio across all filers is 5.09 and the average weighting 1.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORMEDIX INC
ValueSharesWeighting
Q3 2023$158,815
+264.8%
42,923
+290.9%
0.00%
Q2 2023$43,540
-58.5%
10,981
-58.1%
0.00%
Q2 2022$105,000
-58.0%
26,193
-42.6%
0.00%
Q1 2022$250,000
-18.3%
45,642
-32.2%
0.00%
Q4 2021$306,000
+108.2%
67,359
+113.1%
0.00%
Q3 2021$147,000
-19.7%
31,608
+18.8%
0.00%
Q2 2021$183,000
-70.2%
26,609
-56.7%
0.00%
Q1 2021$614,000
+323.4%
61,481
+216.0%
0.00%
Q4 2020$145,000
+133.9%
19,459
+89.6%
0.00%
Q3 2020$62,000
-75.3%
10,263
-63.4%
0.00%
Q2 2019$251,000
-78.5%
28,036
-77.3%
0.00%
Q1 2019$1,169,000123,6950.00%
Other shareholders
CORMEDIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Spinnaker Capital LLC 175,384$649100.00%
PLANNING DIRECTIONS INC 50,000$1850.14%
Castellan Group 30,000$110,7000.08%
Wick Capital Partners, LLC 35,985$133,1450.08%
GSG Advisors LLC 30,000$111,0000.05%
Elliott Investment Management L.P. 1,550,523$5,736,9350.04%
OCCUDO QUANTITATIVE STRATEGIES LP 74,763$276,6230.04%
NOMURA HOLDINGS INC 2,951,532$10,920,6680.03%
American Financial Advisors, LLC 30,527$112,9500.02%
Advisor OS, LLC 25,000$92,5000.01%
View complete list of CORMEDIX INC shareholders